Clinical Trial Update: Dexamethasone Eluting Cochlear Implant: a Pivotal Study [NA]

View source ↗

Summary

MED-EL's dexamethasone-eluting cochlear implant is described as a pivotal study. The trial status is Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss

Drugs mentioned

• Dexamethasone-eluting cochlear implant (dexamethasone)

Snippet

Sponsor: MED-EL Elektromedizinische Geräte GesmbH | Conditions: Cochlear Implant | NA | Status: RECRUITING